Viewing Study NCT03148756

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 11:31 PM

Ignite Modification Date: 2026-02-12 @ 6:14 AM

Study NCT ID: NCT03148756

Status: TERMINATED

Last Update Posted: 2022-04-25

First Post: 2017-05-09

Is NOT Gene Therapy: True

Has Adverse Events: True

Brief Title: Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis

Sponsor: AbbVie

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module